Daiichi Sankyo (India)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi Sankyo (India), India, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
58%
Total
Publications
311
Total Open
Publications
180
Total
Citations
3.7K
Open Access
Percentage
58%
Total
Publications
311
Total Open
Publications
180
Total
Citations
3.7K
Breakdown
Publisher Open
50%
Both
5%
Other Platform Open
3%
Closed
42%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 8%
14
Hybrid 16%
27
No Guarantees 76%
130
Other Platform Open
Domain 80%
20
Preprint 12%
3
Other Internet 12%
3
Public 4%
1
Institution 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 20 |
Europe PMC | Domain | 14 |
bioRxiv | Preprint | 3 |
Aalborg Universitet - VBN Forskningsportal | Other Internet | 2 |
Taylor and Francis Group - Dove Medical Press | Other Internet | 1 |
Semantic Scholar | Public | 1 |
INFN Catania - INFM-OAR | Other Internet | 1 |